Enjoy the event with subtitles available in multiple languages. *Subtitles are AI-generated and may contain inaccuracies.
close
This content is not available in your location
This event is scheduled for
Only logged in users can watch the content
To access AIS Channel content, please allow all cookies. Please click here to configure your preferences.
The demonstration of the company logo is funded by the company only as a participation of the academic event organized by AIS, nonetheless and not in any event shall J&J generate, provide, sponsor or endorse any of the contents transmitted or provided herein. The ownership and entitlement of the company logo shall fully and solely remain with J&J.
Cutting-Edge Treatment for Locally Advanced Gastric Cancer
Healing in China
Share
share
Sep, 2023
Chat
keyboard_arrow_down
Description
keyboard_arrow_down
Since the late 20th century, Chinese medicine has developed rapidly in comparison to the rest of the world, being China one of the countries which have made more significant advances in medical research and treatments. Aiming to provide a comprehensive, in-depth look at how Chinese medicine is practiced and examine its impact on global health, we proudly introduce Meet the Institutions, as part of the Healing in China series, which gives you access to the best centers of excellence in China, and the opportunity to collaborate with these hospitals and participate in activities and projects organized by them.
Hospital & Department Presentation - Dr. Jiafu Ji (China)
Welcome & Introduction - Dr. Jiafu Ji (China)
Digestive Tract Reconstruction After Proximal Gastrectomy - Dr. Ziyu Li (China)
Prevalence of Abdominal Complications After Gastro Enterological Surgery - Dr. Zhouqiao Wu (China)
The Evolution of Gastric Cancer Management in the US - Dr. Martin S. Karpeh (USA)
Gastric Cancer Surgery - Evolution and state of the art of Mini - Invasivity concept in the West - Prof. Domenico D’Ugo (Italy)
Peking University Cancer Hospital (PKUCH) is a leading cancer center in China, excelling in treatment, research, and prevention. We are at the forefront of cancer care with a focus on treatment standardization, clinical trials, and epidemiological studies.
Our hospital leads the way in standardizing cancer therapies, authoring national clinical guidelines, and training physicians nationwide. Through collaboration, we've achieved consistent surgical treatment for GI tumors and introduced innovative approaches like minimally invasive procedures.
PKUCH's Key Laboratory of Carcinogenesis and Translational Research conducts cutting-edge research in cancer genetics, biomarkers, and more. We host China's largest cancer biobank and excel in clinical trials, with over 20 drugs, including Zanubrutinib, developed and approved for the US market.
Our dedication extends to epidemiological research, where we've conducted groundbreaking studies on gastric cancer risk factors. We foster collaboration through the China Precision Cancer Care Consortium and the National Surgical Quality Initiative, benefiting over 350,000 Chinese patients.
